Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Click Chemistry Tools developed novel cross-linking and labeling reagents using click chemistry, used to advance drug discovery, therapeutic approaches, and diagnostic techniques. The company offered small molecule conjugation, protein–protein conjugation, and modification of proteins with bioorthogonal reactive groups. It was acquired by Vector Laboratories in 2022 to expand Vector’s manufacturing and bioconjugation capabilities in proteomic and glycomic research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Click Chemistry Tools.